Trade

with

DaVita HealthCare Partners Inc
(NYSE: DVA)
AdChoices
76.36
+0.14
+0.18%
After Hours :
-
-
-

Open

76.42

Previous Close

76.22

Volume (Avg)

45.40k (833.12k)

Day's Range

76.36-76.36

52Wk Range

52.75-76.36

Market Cap.

-

Dividend Rate ( Yield )

-

Beta

0.69

Shares Outstanding

214.80M

P/E Ratio (EPS)

- (3.15)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Care
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 11.76B

    • Net Income

    • 633.45M

    • Market Cap.

    • -

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 5.54

    • PEG (Price/Earnings Growth) Ratio

    • 0.40

    • Beta

    • 0.69

    • Forward P/E

    • 18.42

    • Price/Sales

    • 1.34

    • Price/Book Value

    • 3.42

    • Price/Cash flow

    • 9.18

      • EBITDA

      • 2.08B

      • Return on Capital %

      • 3.96

      • Return on Equity %

      • 15.26

      • Return on Assets %

      • 3.96

      • Book Value/Share

      • 22.28

      • Shares Outstanding

      • 214.80M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 70.00

        • Credit Rating

        • BB

        • Analysts

        • 4

        • EPS Estimate

        • 4.33

        • Cashflow Estimate

        • 6.77

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 10.80

          • 10.91

          • Net Income

            YTD/YTD (last year)

          • 15.70

          • 13.51

          • Net Income

            Q/Q (last year)

          • -41.90

          • 9.25

          • Sales (Revenue)

            5-Year Annual Average

          • 15.76

          • 22.28

          • Net Income

            5-Year Annual Average

          • 10.60

          • 7.43

          • Dividends

            5-Year Annual Average

          • -

          • 7.69

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 29.55

            • 20.03

            • Pre-Tax Margin

            • 10.34

            • 6.27

            • Net Profit Margin

            • 5.54

            • 3.77

            • Average Gross Margin

              5-Year Annual Average

            • 31.20

            • 20.79

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 11.70

            • 6.01

            • Average Net Profit Margin

              5-Year Annual Average

            • 6.40

            • 210.16B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 1.75

              • 0.69

              • Current Ratio

              • 1.60

              • 1.48

              • Quick Ratio

              • 1.34

              • 0.75

              • Interest Coverage

              • 3.96

              • 11.79

              • Leverage Ratio

              • 3.75

              • 2.42

              • Book Value/Share

              • 22.28

              • 17.00

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 23.87

                • 24.69

                • P/E Ratio 5-Year High

                • 24.23

                • 101.38

                • P/E Ratio 5-Year Low

                • 8.36

                • 15.89

                • Price/Sales Ratio

                • 1.32

                • 0.86

                • Price/Book Value

                • 3.38

                • 3.36

                • Price/Cash Flow Ratio

                • 9.18

                • 11.49

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 15.26

                    (19.40)

                  • 12.59

                    (10.63)

                  • Return on Assets %

                    (5-Year Average)

                  • 3.96

                    (4.90)

                  • 6.43

                    (5.79)

                  • Return on Capital %

                    (5-Year Average)

                  • 7.27

                    (8.60)

                  • 8.91

                    (7.75)

                  • Income/Employee

                  • 11.84k

                  • 8.31k

                  • Inventory Turnover

                  • 97.38

                  • 9.85

                  • Asset Turnover

                  • 0.71

                  • 1.70

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  1.55B
                  Operating Margin
                  13.18
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  9.18
                  Ownership

                  Institutional Ownership

                  89.53%

                  Top 10 Institutions

                  45.14%

                  Mutual Fund Ownership

                  29.82%

                  Float

                  81.30%

                  5% / Insider Ownership

                  1.23%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Mid-Cap Index Fund

                  •  

                    3,491,032

                  • 1.38

                  • 1.63

                  • Vanguard Total Stock Mkt Idx

                  •  

                    3,323,536

                  • 0.57

                  • 1.55

                  • T. Rowe Price Capital Appreciation Fund

                  •  

                    2,196,020

                  • 59.80

                  • 1.02

                  • Vanguard Five Hundred Index Fund

                  •  

                    1,783,544

                  • -3.14

                  • 0.83

                  • Vanguard Institutional Index Fund

                  •  

                    1,740,287

                  • -4.38

                  • 0.81

                  • SPDR® S&P 500 ETF

                  •  

                    1,691,367

                  • 1.59

                  • 0.81

                  • Lord Abbett Fundamental Equity

                  •  

                    1,443,471

                  • 83.70

                  • 0.67

                  • AMG TimesSquare Mid Cap Growth Fund

                  •  

                    1,283,500

                  • -2.81

                  • 0.60

                  • Principal LargeCap Growth Fund I

                  •  

                    1,234,319

                  • 0.00

                  • 0.57

                  • CREF Stock

                  •  

                    1,112,477

                  • -1.59

                  • 0.52

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Berkshire Hathaway Inc

                  •  

                    37,621,152

                  • 0.00%

                  • 17.52

                  • Vanguard Group, Inc.

                  •  

                    13,612,114

                  • +1.92%

                  • 6.34

                  • Brown Investment Advisory Incorporated

                  •  

                    8,073,367

                  • -1.84%

                  • 3.76

                  • State Street Corp

                  •  

                    7,582,892

                  • -6.87%

                  • 3.53

                  • GEICO Indemnity Company

                  •  

                    6,795,084

                  • +50.30%

                  • 3.19

                  • TimesSquare Capital Management, LLC

                  •  

                    5,686,201

                  • +2.87%

                  • 2.65

                  • BlackRock Fund Advisors

                  •  

                    5,362,811

                  • +1.15%

                  • 2.50

                  • Egerton Capital LLP

                  •  

                    4,428,669

                  • +24.93%

                  • 2.06

                  • T. Rowe Price Associates, Inc.

                  •  

                    3,885,661

                  • +47.69%

                  • 1.81

                  • Harding Loevner L.P.

                  •  

                    3,815,215

                  • +0.10%

                  • 1.78

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Care

                  Type

                  Aggressive Growth

                  Style

                  Mid Core

                  DaVita HealthCare Partners Inc was incorporated as a Delaware corporation in 1994. It is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease, ...moreor ESRD. The Company also provides administrative and management support services to a medical services joint venture in which the Company owns a 50% interests. It also provides acute inpatient dialysis services in approximately 700 hospitals and related laboratory services. As of December 31, 2013, it provided dialysis and administrative services in the U.S. through a network of 2,074 outpatient dialysis centers in 45 states and the District of Columbia, serving a total of approximately 163,000 patients. It also provides acute inpatient dialysis services in approximatel...morey 1,000 hospitals and related laboratory services throughout the United States. The United States dialysis and related lab services business. Home-based dialysis services consist of providing equipment and supplies, training, patient monitoring, on-call support services and follow-up assistance to patients who prefer and are able to receive either peritoneal dialysis or hemodialysis treatments in their homes. It provides hospital inpatient hemodialysis services are required for patients with acute kidney failure resulting from trauma, patients in early stages of ESRD and ESRD patients who require hospitalization for other reasons. It owns two separately incorporated, licensed, clinical laboratories, both located in Florida, specializing in ESRD patient testing. These specialized laboratories provide routine laboratory tests covered by the Medicare composite payment rate for dialysis and other physician-prescribed laboratory tests for ESRD patients. The Company's laboratories provide these tests predominantly for its own ESRD patients throughout the United States. It currently operates or provides management and administrative services to 29 outpatient dialysis centers, in which it either owns a non-controlling interest, or is wholly-owned by third parties, under management and administrative services agreements. It continues to face increased competition in the dialysis industry from large and medium-sized providers which compete directly with it for acquisition targets as well as for individual patients.lessless

                  Key People

                  Javier Rodriguez

                  CEO, Divisional

                  Kent J. Thiry

                  CEO/Co-Chairman/Director

                  Craig E. Samitt

                  CEO, Divisional

                  Dr. Garry E. Menzel, PhD

                  CFO

                  Ms. Leanne M. Zumwalt

                  Vice President, Divisional

                  • DaVita HealthCare Partners Inc

                  • 1551 Wewatta Street

                  • Denver, VT 80202

                  • USA.Map

                  • Phone: +1 303 405-2100

                  • Fax: +1 310 792-8928

                  • davita.com

                  Incorporated

                  1994

                  Employees

                  57,400

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: